Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-induced granulomatous lung disease.

Kamel Marzouk1, Samer Saleh, Mouhamed Kannass

  • 1Division of Pulmonary and Critical Care Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California 90033, USA. marzouk@usc.edu

Current Opinion in Pulmonary Medicine
|August 19, 2004
PubMed
Summary

Interferon therapy can trigger or worsen sarcoidosis. Discontinuing interferon often resolves the condition, though corticosteroids may sometimes be needed for treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a noncanonical redox cofactor platform in Saccharomyces cerevisiae.

Metabolic engineering·2026
Same author

Expanding the scope of redox-balance growth coupling techniques with a carbon co-feeding strategy.

Metabolic engineering·2026
Same author

Expanding the scope of redox-balance growth coupling techniques with a carbon cofeeding strategy.

bioRxiv : the preprint server for biology·2026
Same author

Activation-Free Upgrading of Carboxylic Acids to Aldehydes and Alcohols.

bioRxiv : the preprint server for biology·2025
Same author

A Sequence Motif Enables Widespread Use of Non-Canonical Redox Cofactors in Natural Enzymes.

bioRxiv : the preprint server for biology·2025
Same author

Surface Functionalization of WS<sub>2</sub> Nanosheets with Alkyl Chains for Enhancement of Dispersion Stability and Tribological Properties.

ACS applied materials & interfaces·2021

Area of Science:

  • Immunology
  • Dermatology
  • Oncology

Background:

  • Interferons are utilized for treating diverse conditions due to their antiviral, antigrowth, and immunomodulatory properties.
  • Exogenous interferons can stimulate a Th-1 immune response, crucial in granuloma formation.
  • Clinicians may increasingly encounter sarcoidosis cases due to the expanding use of interferon therapies.

Observation:

  • This review details three unique cases of sarcoidosis induced by interferon therapy.
  • The literature on interferon-induced sarcoidosis is reviewed, highlighting recent findings.

Findings:

  • Interferon therapy is a potential cause or exacerbating factor for sarcoidosis.
  • In most cases, sarcoidosis resolves upon cessation of interferon treatment.

Related Experiment Videos

  • Corticosteroid treatment may occasionally be required for managing interferon-induced sarcoidosis.

    • Implications:

    • Awareness of interferon-induced sarcoidosis is crucial for clinicians managing patients on these therapies.
    • Understanding the immunomodulatory effects of interferons aids in predicting and managing adverse reactions.
    • Prompt recognition and management can lead to favorable outcomes, often involving simple discontinuation of the offending agent.